Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.8000
0.00 (0.00%)
At close: Dec 5, 2025
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 21.58 million as of December 5, 2025. Its market cap has increased by 251.11% in one year.
Market Cap
21.58M
Enterprise Value
21.01M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 21.58M, a decrease of -77.88%. That is a compound annual growth rate of -31.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 21.58M | 203.66% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.57B |
| Haleon | 32.16B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |